Search research articles
Contact Us
Filters
Showing results (281-290 of 292) with videos related to
Page
of 30
Sort By:
Nature
|
March 19, 2024
Author Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma
Guangchun Han, Ansam Sinjab, Zahraa Rahal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2021
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
L Federico, D J McGrail, S-E Bentebibel, et al.
Cancer Discovery
|
May 11, 2021
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing
Ansam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, et al.
Journal of the National Cancer Institute
|
September 15, 2021
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas
Ichidai Tanaka, Delphine Dayde, Mei Chee Tai, et al.
BMC Infectious Diseases
|
June 27, 2022
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
Manuel Rojas, Yhojan Rodríguez, Juan Carlos Hernández, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Nature Communications
|
November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Melinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 292) with videos related to
Sort By:
Page
of 30
Nature
|
March 19, 2024
Author Correction: An atlas of epithelial cell states and plasticity in lung adenocarcinoma
Guangchun Han, Ansam Sinjab, Zahraa Rahal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2021
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
L Federico, D J McGrail, S-E Bentebibel, et al.
Cancer Discovery
|
May 11, 2021
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing
Ansam Sinjab, Guangchun Han, Warapen Treekitkarnmongkol, et al.
Journal of the National Cancer Institute
|
September 15, 2021
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas
Ichidai Tanaka, Delphine Dayde, Mei Chee Tai, et al.
BMC Infectious Diseases
|
June 27, 2022
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
Manuel Rojas, Yhojan Rodríguez, Juan Carlos Hernández, et al.
Nature Medicine
|
February 19, 2021
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Tina Cascone, William N William, Annikka Weissferdt, et al.
Nature Medicine
|
March 17, 2023
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Nature Communications
|
November 25, 2025
Nivolumab plus ipilimumab induce hyper-progression in renal medullary carcinoma: results of a phase II trial and preclinical evidence
Melinda Soeung, Xinmiao Yan, Ciro Zanca, et al.
Cancer Discovery
|
May 19, 2018
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E Goldberg, Danielle M Greenawalt, et al.
Page
of 30